A Single-Session Intervention for Families on Waitlists for Child Anxiety Treatment
aSSI
1 other identifier
interventional
59
1 country
1
Brief Summary
Lengthy wait times to access treatment for youth anxiety disorders is a critical issue. To help address this issue, investigators will pursue the following aims in N = 65 families on waitlists for outpatient youth anxiety psychosocial treatment. Aim 1 Pilot Phase: Develop and pilot a single session intervention (SSI) tailored for families on waitlists for outpatient psychosocial treatment for youth anxiety disorders. Investigators will pilot the single session intervention (SSI) with N = 5 families and use cognitive response interviewing to obtain data from parents and children, ensuring the content is understandable and accessible. The SSI will include psychoeducation on the cognitive behavioral conceptualization of anxiety, introduction to self-regulation strategies to manage physiological manifestations of anxiety, and cognitive restructuring of anxiogenic thoughts. The SSI will also involve parents and present strategies on how parents can support their children in managing anxious feelings and thoughts. Investigators will refine the SSI based on these data. Following the Pilot Phase, investigators will enroll an additional N = 60 families and randomize them to either the SSI (n = 30) or waitlist control (n = 30). Aim 2 Test Phase Acceptability, and Satisfaction: Examine acceptability of the refined SSI, as well as satisfaction with the SSI. Investigators hypothesize that users will find the module to be acceptable and will report high satisfaction. Aim 3 Test Phase Anxiety Outcomes: Demonstrate reductions in youth anxiety symptom severity. Investigators hypothesize that anxiety symptom severity and impairment will be significantly lower among youth who receive the refined SSI relative to youth on waitlist control. The main risk or discomfort from this research is that participants might feel uncomfortable answering questions about their behavior and feelings. Another possible risk is breach of confidentiality that could identify a participant as having elevated levels of anxiety. The benefits of this SSI would include increasing accessibility and scalability of treatment for youth anxiety disorders. Overall, this study will provide critically needed data to advance resource efficient treatment options for youth anxiety disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2023
CompletedFirst Submitted
Initial submission to the registry
February 24, 2023
CompletedFirst Posted
Study publicly available on registry
May 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 9, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedResults Posted
Study results publicly available
November 24, 2025
CompletedNovember 24, 2025
October 1, 2025
2.3 years
February 24, 2023
October 23, 2025
November 12, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Screen for Child Anxiety Related Emotional Disorders - Parent Version at Posttreatment
Posttreatment parent rating of youth anxiety symptom severity over the past week. The name of the measure is the Screen for Child Anxiety Related Emotional Disorders - Parent Version (SCARED-P). The SCARED-P is a parent rated measure of the severity of youths' anxiety symptoms. Total scores on the SCARED-P range from 0 to 82, with higher scores representing more severe anxiety.
1 week after first session
Screen for Child Anxiety Related Emotional Disorders - Child Version at Posttreatment
Posttreatment child rating of youth anxiety symptom severity over the past week. The name of the measure is the Screen for Child Anxiety Related Emotional Disorders - Child Version (SCARED-C). The SCARED-C is a child rated measure of the severity of youths' anxiety symptoms. Total scores on the SCARED-C range from 0 to 82, with higher scores representing more severe anxiety.
1 week after first session
Screen for Child Anxiety Related Emotional Disorders - Parent Version at Follow up
Follow up parent rating of youth anxiety symptom severity over the past 3 weeks. The name of the measure is the Screen for Child Anxiety Related Emotional Disorders - Parent Version (SCARED-P). The SCARED-P is a parent rated measure of the severity of youths' anxiety symptoms. Total scores on the SCARED-P range from 0 to 82, with higher scores representing more severe anxiety.
4 weeks after first session
Screen for Child Anxiety Related Emotional Disorders - Child Version at Follow-Up
Follow up child rating of youth anxiety symptom severity over the past 3 weeks. The name of the measure is the Screen for Child Anxiety Related Emotional Disorders - Child Version (SCARED-C). The SCARED-C is a child rated measure of the severity of youths' anxiety symptoms. Total scores on the SCARED-C range from 0 to 82, with higher scores representing more severe anxiety.
4 weeks after first session
Secondary Outcomes (18)
Screen for Child Anxiety Related Emotional Disorders - Child Version at Pre
first session at baseline
Screen for Child Anxiety Related Emotional Disorders - Parent Version at Pre
first session at baseline
Child Anxiety Impact Scale - Parent Version at Pre
first session at baseline
Child Anxiety Impact Scale - Child Version at Pre
first session at baseline
Child Anxiety Impact Scale - Parent Version at Posttreatment
1 week after first session
- +13 more secondary outcomes
Study Arms (2)
Waitlist Control
NO INTERVENTIONParticipants complete pre, post, and follow-up questionnaires. They have the option to view the SSI module after completing follow-up questionnaires.
Single Session Intervention Receivers
ACTIVE COMPARATORParticipants complete pre then receive the SSI module. Then they complete post and follow-up questionnaires.
Interventions
Single Session Intervention (SSI) module for youth with anxiety disorders and their parents. The SSI module will include psychoeducation on the cognitive behavioral conceptualization of anxiety, introduction to self-regulation strategies to manage physiological manifestations of anxiety, and cognitive restructuring of anxiogenic thoughts. The SSI module will also involve parents and present strategies on how parents can support their children in managing anxious feelings and thoughts.
Eligibility Criteria
You may qualify if:
- Be between ages 7 and 17 years
- Endorse clinically elevated anxiety symptoms on either parent or youth report, as indicated by a score \> 25 on the Screen for Child Anxiety and Related Emotional Disorders-Child or Parent Versions (SCARED-C/P).
You may not qualify if:
- Parent report of past diagnosis of Autism Spectrum Disorder, Intellectual Disability, Bipolar Disorder, Tourette's Disorder, Psychotic Disorders, or Substance Use Disorders
- Show high likelihood of hurting themselves or others
- Not having access/connectivity needed for telehealth video conferencing to complete the module.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Florida International University
Coral Gables, Florida, 33156, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Jeremy Pettit
- Organization
- Florida International University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2023
First Posted
May 3, 2023
Study Start
February 10, 2023
Primary Completion
June 9, 2025
Study Completion
October 1, 2025
Last Updated
November 24, 2025
Results First Posted
November 24, 2025
Record last verified: 2025-10